{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Valproic Acid: Special Considerations and Targeted Monitoring

Activity Steps

Purpose of Activity

To provide clinically significant information for safe prescribing and monitoring of patients who receive valproic acid (VPA).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify the uses, pharmacokinetics, cautions, and contraindications of VPA.
  2. Select adverse drug reactions (ADRs) that may occur with the use of VPA.
Price: $17.95


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours

Test Code: JNN0217
Published: Feb 2017
Expires: 12/4/2020
Required Passing Score: 14/20 (70%)
Authors: Angela Collins-Yoder, PhD, RN, CCNS, ACNS, BC; Jordan Lowell, BSN, RN